Kexing Biopharm Co., Ltd. (688136.SS) SHH

32.67

+0.07(+0.21%)

Updated at December 05 03:00PM

Currency In CNY

Valuation

Market Cap4.3B
Enterprise Value4.64B
P/E Ratio50.69
PEG Ratio1.99
Price/Sales Ratio4.21
Price/Book Ratio3.71
Enterprise/Revenue4.81
Enterprise/EBITDA41.69

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.08
Operating Margin0.09

Management Effectiveness

Return On Assets0.04
Return On Equity0.08

Income Statement

Revenue1.41B
Revenue/Share7.64
Gross Profit962.73M
EBITDA184.6M
Net Income31.48M
Diluted EPS0.16

Balance Sheet

Total Cash612.79M
Total Cash/Share3.09
Total Debt1.4B
Total Debt/Equity0.82
Current Ratio1.5
Book Value Per Share8.66

Price History

52-Week Change87.89
52-Week High63.99
52-Week Low16.71
Moving Average 50 Days37.05
Moving Average 200 Days38.7

Statistics

Average Volume3.43M
Shares Outstanding198.12M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.08
Trailing Annual Dividend Yield0.25
Payout Ratio0.37
Last Split FactorN/A
Last Split DateN/A